Chi Wu

824 total citations
8 papers, 547 citations indexed

About

Chi Wu is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Chi Wu has authored 8 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 2 papers in Immunology. Recurrent topics in Chi Wu's work include Tuberculosis Research and Epidemiology (4 papers), Mycobacterium research and diagnosis (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Chi Wu is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Mycobacterium research and diagnosis (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Chi Wu collaborates with scholars based in China and United States. Chi Wu's co-authors include Jiuxin Qu, Qing Zhu, Zhaofang Jiang, Xiaoyong Li, Guobin Zhang, Xiaohe Li, Lei Liu, Boping Zhou, Xinchun Chen and Qunyi Deng and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and Cellular Immunology.

In The Last Decade

Chi Wu

8 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi Wu China 5 368 165 138 58 49 8 547
Gira Patel United States 11 286 0.8× 118 0.7× 96 0.7× 31 0.5× 208 4.2× 23 645
Toru Kubo Japan 11 150 0.4× 89 0.5× 173 1.3× 60 1.0× 80 1.6× 30 509
Fatma Berri France 11 264 0.7× 162 1.0× 213 1.5× 28 0.5× 102 2.1× 19 580
Felipe Pérez‐García Spain 15 386 1.0× 45 0.3× 190 1.4× 23 0.4× 111 2.3× 35 587
Gabriela Barcenas‐Morales United Kingdom 12 217 0.6× 386 2.3× 324 2.3× 51 0.9× 67 1.4× 22 653
Qunyi Deng China 13 429 1.2× 281 1.7× 294 2.1× 161 2.8× 96 2.0× 15 666
Violette Dirix Belgium 13 218 0.6× 118 0.7× 317 2.3× 106 1.8× 52 1.1× 34 486
Rowa Y. Alhabbab Saudi Arabia 13 266 0.7× 193 1.2× 40 0.3× 23 0.4× 138 2.8× 32 556
Urara Kohdera Japan 15 339 0.9× 100 0.6× 269 1.9× 100 1.7× 68 1.4× 38 695
Eleonora Cimini Italy 16 188 0.5× 408 2.5× 140 1.0× 14 0.2× 112 2.3× 56 728

Countries citing papers authored by Chi Wu

Since Specialization
Citations

This map shows the geographic impact of Chi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Wu more than expected).

Fields of papers citing papers by Chi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Wu. The network helps show where Chi Wu may publish in the future.

Co-authorship network of co-authors of Chi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Wu. A scholar is included among the top collaborators of Chi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Wu. Chi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zheng, Wenshu, Liqiang Li, Chi Wu, et al.. (2025). Enhanced diagnosis of multi-drug-resistant microbes using group association modeling and machine learning. Nature Communications. 16(1). 2933–2933. 2 indexed citations
2.
Ding, Feng, Wanfei Liu, Chi Wu, et al.. (2025). Whole-genome sequencing reveals transmission pattern and drug resistance of Mycobacterium tuberculosis intra- or inter-hosts. Frontiers in Cellular and Infection Microbiology. 14. 1488547–1488547. 1 indexed citations
3.
Qu, Jiuxin, Wanfei Liu, Shuyan Chen, et al.. (2024). Deep Amplicon Sequencing Reveals Culture-dependent Clonal Selection of Mycobacterium tuberculosis in Clinical Samples. Genomics Proteomics & Bioinformatics. 22(6). 3 indexed citations
4.
Chen, Shuyan, Qing Zhu, Chi Wu, et al.. (2021). Clinical and etiological analysis of co‐infections and secondary infections in COVID‐19 patients: An observational study. The Clinical Respiratory Journal. 15(7). 815–825. 37 indexed citations
5.
Qu, Jiuxin, Chi Wu, Xiaoyong Li, et al.. (2020). Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinical Infectious Diseases. 71(16). 2255–2258. 212 indexed citations
6.
An, Yan, Yanfang Guan, Yaping Xu, et al.. (2019). The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma.. PubMed. 11(10). 6462–6474. 44 indexed citations
7.
Zhang, Mingxia, Zheng Wang, Michael W. Graner, et al.. (2011). B cell infiltration is associated with the increased IL-17 and IL-22 expression in the lungs of patients with tuberculosis. Cellular Immunology. 270(2). 217–223. 31 indexed citations
8.
Chen, Xinchun, Boping Zhou, Qunyi Deng, et al.. (2007). CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clinical Immunology. 123(1). 50–59. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026